Candia, Jimboy M.
HRN: 20-48-83 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/09/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
01/09/2023
01/16/2023
IV
500mg
Q8
Soft Tissue Mass, Abcess(?) Right Parietal Are
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes